Literature DB >> 24169521

A novel indel in exon 9 of APC upregulates a 'skip exon 9' isoform and causes very severe familial adenomatous polyposis.

Peh Yean Cheah1, Yu Hui Wong2, Poh Koon Koh2, Carol Loi2, Min Hoe Chew2, Choong Leong Tang2.   

Abstract

Germline mutation in the adenomatous polyposis coli (APC) gene causes the majority (80%) of familial adenomatous polyposis (FAP), an autosomal dominantly inherited form of colorectal cancer (CRC). Mutation in 5'end of exon 9 of APC usually results in an attenuated form of FAP (aFAP), characterized by later age of onset and fewer polyps. The presence of exon 9a, an in-frame isoform with exon 8 spliced to 3'end of exon 9, modulates any deleterious effect of the mutation. A third lowly expressed isoform that completely skips exon 9 is present in both healthy individuals and FAP patients. We report here an interesting case of a proband with an APC mutation in 5'end of exon 9 that presented with six synchronous advanced CRCs at age 37. The novel insertion-deletion (indel) at codon 409, c.1226-1229delTTTTinsAAA, caused upregulation of the 'skip exon 9' isoform, r934-1312del, resulting in a premature stop codon at exon 10 and a truncated protein that removed all of the β-catenin (CTNNB1) binding motifs, thus activating the downstream T-cell transcription factor (Tcf) pathway. Exon 9a isoform was concomitantly downregulated. This finding emphasizes the necessity of examining the various isoforms of exon 9 to avoid clinical mismanagement and counseling based on just the mutation site by genomic DNA sequencing alone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24169521      PMCID: PMC4023219          DOI: 10.1038/ejhg.2013.245

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  15 in total

Review 1.  The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.

Authors:  O M Sieber; I P Tomlinson; H Lamlum
Journal:  Mol Med Today       Date:  2000-12

2.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 3.  A genomic view of mosaicism and human disease.

Authors:  Leslie G Biesecker; Nancy B Spinner
Journal:  Nat Rev Genet       Date:  2013-05       Impact factor: 53.242

4.  A family with attenuated familial adenomatous polyposis due to a mutation in the alternatively spliced region of APC exon 9.

Authors:  J Young; L A Simms; J Tarish; R Buttenshaw; N Knight; G J Anderson; A Bell; B Leggett
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

Review 5.  Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature.

Authors:  M H Nieuwenhuis; H F A Vasen
Journal:  Crit Rev Oncol Hematol       Date:  2006-10-24       Impact factor: 6.312

6.  Germline mutations are frequent in the APC gene but absent in the beta-catenin gene in familial adenomatous polyposis patients.

Authors:  X Cao; K W Eu; F Seow-Choen; P Y Cheah
Journal:  Genes Chromosomes Cancer       Date:  1999-08       Impact factor: 5.006

7.  APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis.

Authors:  R B van der Luijt; H F Vasen; C M Tops; C Breukel; R Fodde; P Meera Khan
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

8.  Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis.

Authors:  Randall W Burt; Mark F Leppert; Martha L Slattery; Wade S Samowitz; Lisa N Spirio; Richard A Kerber; Scott K Kuwada; Deborah W Neklason; James A Disario; Elaine Lyon; J Preston Hughes; William Y Chey; Raymond L White
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

9.  Evidence for a novel exon in the coding region of the adenomatous polyposis coli (APC) gene.

Authors:  L Xia; K A St Denis; B Bapat
Journal:  Genomics       Date:  1995-08-10       Impact factor: 5.736

10.  A distinct mutation on the alternative splice site of APC exon 9 results in attenuated familial adenomatous polyposis phenotype.

Authors:  Florentia Fostira; Drakoulis Yannoukakos
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

View more
  4 in total

1.  Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.

Authors:  Nadia Gagnon; Pascale Boily; Catherine Alguire; Gilles Corbeil; Irina Bancos; Mathieu Latour; Catherine Beauregard; Katia Caceres; Zaki El Haffaf; Fred Saad; Harold J Olney; Isabelle Bourdeau
Journal:  Endocrine       Date:  2020-02-22       Impact factor: 3.633

2.  A distinct APC pathogenic germline variant identified in a southern Thai family with familial adenomatous polyposis.

Authors:  Worrawit Wanitsuwan; Sukanya Vijasika; Pichai Jirarattanasopa; Sukanya Horpaopan
Journal:  BMC Med Genomics       Date:  2021-03-19       Impact factor: 3.063

3.  CHERP Regulates the Alternative Splicing of pre-mRNAs in the Nucleus.

Authors:  Yasutaka Yamanaka; Takaki Ishizuka; Ken-Ichi Fujita; Naoko Fujiwara; Masashi Kurata; Seiji Masuda
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

Review 4.  Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment.

Authors:  Yanyan Chen; Mengxi Huang; Xiaolong Liu; Yadi Huang; Chao Liu; Jialong Zhu; Gongbo Fu; Zengjie Lei; Xiaoyuan Chu
Journal:  Cell Death Dis       Date:  2021-07-30       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.